Publication Name	World Journal of Virology
Manuscript ID	34045
Country	Japan

Received	2017-03-23 16:49
Peer-Review Started	2017-03-24 16:53
To Make the First Decision	2017-05-10 17:25
Return for Revision	2017-05-19 06:49
Revised	2017-07-21 07:03
Second Decision	2017-07-28 05:09
Accepted by Journal Editor-in-Chief	2017-07-29 14:13
Accepted by Executive Editor-in-Chief	2017-08-04 06:21
Articles in Press	2017-08-04 06:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-08-08 09:16
Publish the Manuscript Online	2017-08-09 04:13

ISSN	2220-3249 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Virology
Manuscript Type	Field of Vision
Article Title	Additional attention to combination antiretroviral therapy-related lipodystrophy
Manuscript Source	Invited Manuscript
All Author List	Norihiko Kobayashi, Masako Nakahara, Masako Oka and Kumiko Saeki
Funding Agency and Grant Number
Corresponding Author	Kumiko Saeki, MD, PhD, Department of Disease Control, Research Institute, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo 162-8655, Japan. saeki@ri.ncgm.go.jp
Key Words	Combination antiretroviral therapy; Lipodystrophy; Protease inhibitor; Reverse transcriptase inhibitor; Human immunodeficiency virus
Core Tip	Development of lipodystrophy in patients re¬ceiving combination antiretroviral therapy (cART) has been a serious problem. Although it was first reported in patients taking proteinase inhibitors, other types of anti-human immunodeficiency virus (HIV) agents also cause lipodystrophy. A recent publication in World Journal of Virology reported unexpected synergism among anti-HIV drugs with different mechanisms of action in inhibiting adipogenesis in vitro. To elucidate the molecular basis for cART-related lipodystrophy, multi-faceted approaches should be taken with a deeper understanding of the development and organization of adipose tissues.
Publish Date	2017-08-09 04:13
Citation	Kobayashi N, Nakahara M, Oka M, Saeki K. Additional attention to combination antiretroviral therapy-related lipodystrophy. World J Virol 2017; 6(3): 49-52
URL	http://www.wjgnet.com/2220-3249/full/v6/i3/49.htm
DOI	http://dx.doi.org/10.5501/wjv.v6.i3.49

Full Article (PDF)	WJV-6-49.pdf
Full Article (Word)	WJV-6-49.doc
Manuscript File	34045-Review.docx
Answering Reviewers	34045-Answering reviewers.pdf
Audio Core Tip	34045-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	34045-Conflict-of-interest statement.pdf
Copyright License Agreement	34045-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	34045-Language certificate.pdf
Peer-review Report	34045-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	34045-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	34045-Scientific misconduct check.pdf
Scientific Editor Work List	34045-Scientific editor work list.pdf